GCMG vs JAZZ · P/E 21, rev $259.1M vs P/E 1988, rev $2.28B
GCM Grosvenor Inc (GCMG) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
GCM Grosvenor Inc (GCMG) is a asset management company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported GCMG revenue for 2026-06-30 was $259.1M. Net income was $15.0M. GCMG currently screens at market cap $641.9M and trailing P/E 21.3.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
GCMG currently screens at market cap $641.9M and trailing P/E 21.3. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the GCMG and JAZZ stock pages for the full models.
Not investment advice.